Growth Metrics

Insulet (PODD) Revenue Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.63%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.01%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 5.28%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 15.36%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 10.52%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.73%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 17.14%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.92%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.43%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 28.61%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 28.61%
Dec 31, 2025 28.47%
Sep 30, 2025 27.50%
Jun 30, 2025 29.43%
Mar 31, 2025 32.07%
Dec 31, 2024 22.25%
Sep 30, 2024 25.43%
Jun 30, 2024 23.41%
Mar 31, 2024 20.97%
Dec 31, 2023 27.48%
Sep 30, 2023 22.74%
Jun 30, 2023 20.56%
Mar 31, 2023 21.84%
Dec 31, 2022 20.86%
Sep 30, 2022 21.06%
Jun 30, 2022 19.13%
Mar 31, 2022 15.67%
Dec 31, 2021 25.63%
Sep 30, 2021 22.18%
Jun 30, 2021 27.91%
Mar 31, 2021 26.38%
Dec 31, 2020 23.54%
Sep 30, 2020 24.32%
Jun 30, 2020 27.28%
Mar 31, 2020 24.86%
Dec 31, 2019 26.45%
Sep 30, 2019 26.51%
Jun 30, 2019 26.58%
Mar 31, 2019 25.26%
Dec 31, 2018 25.31%
Sep 30, 2018 28.39%
Jun 30, 2018 27.06%
Mar 31, 2018 36.92%
Dec 31, 2017 21.62%
Sep 30, 2017 17.54%
Jun 30, 2017 15.08%
Mar 31, 2017 13.72%
Dec 31, 2016 14.76%
Sep 30, 2016 15.80%
Jun 30, 2016 13.27%
Mar 31, 2016 12.29%
Dec 31, 2015 13.16%
Sep 30, 2015 9.25%
Jun 30, 2015 5.86%
Mar 31, 2015 0.27%
Dec 31, 2014 15.42%
Sep 30, 2014 18.91%
Jun 30, 2014 30.76%
Mar 31, 2014 34.76%
Dec 31, 2013 35.14%
Sep 30, 2013 33.89%
Jun 30, 2013 37.86%